News

Researchers at Tel Aviv University's Gray Faculty of Medical & Health Sciences conducted a series of experiments using ...
Relacorilant/nab-paclitaxel significantly improved PFS and OS vs nab-paclitaxel alone in platinum-resistant ovarian cancer.